Andrew O. Larsen
Merchant & GouldGeneral
Experience10 yrs
Elite Ratings
--
Practice Areas
Biotech (25 cases)
Reexam/Aband. (2 cases)
Chemical Biotech (1 case)
Software, Security (1 case)
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
L4
A
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00625 | Pfizer Inc v. Natco Pharma Ltd | 05/23/24 | Challenger | |
| 1:23-CV-01019 | Celgene Corp v. Natco Pharma Ltd | 09/18/23 | Challenger | |
| 1:23-CV-01008 | Celgene Corp v. Teva Pharma Inc | 09/13/23 | Challenger | |
| 2:23-CV-03959 | Janssen Pharmaceutica NV v. Natco Pharma Ltd | 07/25/23 | Challenger | |
| 1:23-CV-00747 | CMP Development LLC v. Hetero USA Inc | 07/10/23 | Patent Owner | |
| 1:22-CV-01480 | Taiho Pharmaceutical Co Ltd v. Natco Pharma Ltd | 11/10/22 | Challenger | |
| 1:22-CV-00852 | Gilead Sciences Inc v. Natco Pharma Ltd | 06/23/22 | Challenger | |
| 1:22-CV-00615 | Gilead Sciences Inc v. Lupin Ltd | 05/09/22 | Challenger | |
| 1:22-CV-00154 | Acerta Pharma BV v. Alembic Pharma Ltd | 02/02/22 | Challenger | |
| 1:22-CV-00155 | Acerta Pharma BV v. Natco Pharma Ltd | 02/02/22 | Challenger |